Telomerase activity and telomere lenght in the haemopoietic system: Changes with aging, disease, and therapy

Journal of Anti-Aging Medicine

Volumn 3, Issue 4, 2000, Pages 389-395

  Robertson, J D ^a   Wynn, R F ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

AGING; ANEMIA; BONE MARROW TRANSPLANTATION; CANCER; CANCER CELL; ENZYME ACTIVITY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; LEUKOCYTE; PRIORITY JOURNAL; REVIEW; TELOMERE;

EID: 0034503056     PISSN: 10945458     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.1.2000.3.389     Document Type: Review

References (42)

1. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes
2. Mammalian telomere dynamics: Healing, fragmentation shortening and stabilization
3. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon
4. Evidence for a critical telomere length in senescent human fibroblasts
5. Telomere reduction in human colorectal carcinoma and with ageing
6. In vivo loss of telomeric repeats with age in humans
7. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age
8. Recognition and elongation of telomeres by telomerase
9. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
10. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres
11. TIN2, a new regulator of telomere length in human cells
12. Telomerase activity in human germline and embryonic tissues and cells
13. Telomerase activity in hematopoietic cells is associated with self-renewal potential
14. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
15. Mechanism of telomerase induction during T cell activation
16. Tales of tails: Regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging
17. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood
18. Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns
19. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening
20. Telomerase activity in normal leukocytes and in hematologic malignancies
21. The biological aging of bone marrow
22. The rate of telomere sequence loss in human leukocytes varies with age
23. Rapid telomere shortening in children
24. Telomere shortening in leucocyte subsets of long-term survivors of allogeneic bone marrow transplantation
25. Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age
26. Evidence that hematopoiesis may be a stochastic process in vivo
27. Clinical implications of telomerase activity levels in acute leukemia
28. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes
29. Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression
30. Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia
31. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia
32. Progressive telomere shortening in aplastic anemia
33. Accelerated telomere shortening and telomerase activation in Fanconi's anaemia
34. The assessment of the hematopoietic reservoir after immunosuppressive therapy or bone marrow transplantation in severe aplastic anemia
35. In vivo telomere dynamics of human hematopoietic stem cells
36. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants
37. Changes of telomere length in children after hematopoietic stem cell transplantation
38. Telomere length changes in patients undergoing hematopoietic stem cell transplantation
39. Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation
40. Haemopoietic reconstitution after allogeneic bone marrow transplantation in man: Recovery of haemopoietic progenitors (CFU-Mix, BFU-E and CFU-GM)
41. Deficient reconstitution of early progenitors after allogeneic bone marrow transplantation
42. Different repopulation kinetics of erythroid (BFU-E), myeloid (CFU-GM) and T lymphocyte (TL-CFU) progenitor cells after autologous and allogeneic bone marrow transplantation